-B(01779.HK): It is recommended to adopt H-share equity purchase plan and H-share stock incentive plan.

Capital Watch APP news, Tianchen Biology-B (01779.HK) announced that on July 15, 2026, the board of directors has resolved to recommend the adoption of the company's H-share subscription plan and H-share stock incentive plan.